Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT96
Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer64
Non-local mean denoising using multiple PET reconstructions46
Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT41
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT36
A review on AI in PET imaging35
The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review30
High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients28
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images27
Preoperative prediction of regional lymph node metastasis of colorectal cancer based on 18F-FDG PET/CT and machine learning27
Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery24
Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning23
18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma23
[18F]FDG PET/MRI in rectal cancer23
Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results23
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients22
Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer22
Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy19
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging18
Deep learning-based attenuation correction for brain PET with various radiotracers18
The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol18
Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT18
Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT16
Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC15
Revisiting detection of in-transit metastases in melanoma patients using digital 18F-FDG PET/CT with small-voxel reconstruction15
Clinical practice guidelines for high-resolution breast PET, 2019 edition14
Performance evaluation of dedicated brain PET scanner with motion correction system14
Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition)14
Artificial intelligence for nuclear medicine in oncology14
Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas13
Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?13
131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy13
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients12
An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging12
Attenuation correction using deep learning for brain perfusion SPECT images12
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab12
Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand12
[18F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis12
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of 225Ac-DOTA-rituximab using 64Cu-DOTA-rituximab11
A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods11
The application of artificial intelligence in nuclear cardiology11
What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature11
Predictive factors of tumor sink effect: Insights from 177Lu-Prostate-specific membrane antigen therapy11
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen11
Deep learning for image classification in dedicated breast positron emission tomography (dbPET)11
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)11
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study10
Whole-body vibration exercise and training increase regional CBF in mild cognitive impairment with enhanced cognitive function10
Comparison of 68Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis10
Feasibility of ultra-high-speed acquisition in xSPECT bone algorithm: a phantom study with advanced bone SPECT-specific phantom10
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice10
Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses10
Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism10
Test–retest repeatability of quantitative bone SPECT/CT10
Pretreatment [18F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma9
Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma9
Initial evaluation of a new maximum-likelihood attenuation correction factor-based attenuation correction for time-of-flight brain PET9
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients9
Deep learning-based detection of parathyroid adenoma by 99mTc-MIBI scintigraphy in patients with primary hyperparathyroidism9
Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging9
Correlation between noise pareidolia test scores for visual hallucinations and regional cerebral blood flow in dementia with Lewy bodies9
Prognostic and predictive values of interim 18F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis9
Recent topics of the clinical utility of PET/MRI in oncology and neuroscience9
Performance of digital PET/CT compared with conventional PET/CT in oncologic patients: a prospective comparison study9
Deep learning exploration for SPECT MPI polar map images classification in coronary artery disease9
18F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer9
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma8
18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma8
Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images8
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma8
Metal artifact reduction for improving quantitative SPECT/CT imaging8
Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by 14C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT8
Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study8
Pretreatment 18F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma8
From FDG and beyond: the evolving potential of nuclear medicine8
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive,8
Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer’s disease8
A review of harmonization strategies for quantitative PET8
New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies8
The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer8
Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials8
11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis7
Application of artificial intelligence in brain molecular imaging7
Brain PET motion correction using 3D face-shape model: the first clinical study7
Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging7
Role of volumetric parameters obtained from 68 Ga-PSMA PET/CT and 18F-FDG PET/CT in predicting overall survival in patients with mCRPC receiving taxane therapy7
68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer7
Detection of Alzheimer’s disease using ECD SPECT images by transfer learning from FDG PET7
Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by 18F-FDG PET/CT7
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions7
Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area7
Clinicopathological variables that correlate with sestamibi positivity in uniglandular parathyroid disease: a retrospective analysis of 378 parathyroid adenomas7
Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer7
Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET7
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-2237
Automatic quantification package (Hone Graph) for phantom-based image quality assessment in bone SPECT: computerized automatic classification of detectability7
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography6
13N-ammonia positron emission tomography-derived left-ventricular strain in patients after heart transplantation validated using cardiovascular magnetic resonance feature tracking as reference6
Correlations between whole body volumetric parameters of 68Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients6
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranostics6
Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma6
Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy6
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer6
The feasibility of ultralow-activity 18F-FDG dynamic PET imaging in lung adenocarcinoma patients through total-body PET/CT scanner6
Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma6
Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan6
Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG and a novel dose conversion method, RAP6
Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft6
Outcome of patients with differentiated thyroid cancer treated with empirical radioiodine therapy on the basis of Thyroglobulin Elevation Negative Iodine Scintigraphy (TENIS) syndrome without structur6
Test–retest reproducibility of dopamine transporter density measured with [18F]FP-CIT PET in patients with essential tremor and Parkinson’s disease6
Prognostic value of [18F]FDG-PET prior to [131I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL)6
Brown tumors in nuclear medicine: a systematic review6
Diagnostic value of [18F]Fluorocholine PET/CT in detection of primary medullary thyroid cancer6
Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET6
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific me6
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals6
Association between diffuse renal uptake of 18F-FDG and acute kidney injury6
Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia6
Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess6
The relationship between global cardiac and regional left atrial sympathetic innervation and epicardial fat in patients with atrial fibrillation6
0.078144073486328